LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹2,636 Cr | ₹2,390 Cr | ₹820 Cr | ₹992 Cr | ₹1,153 Cr |
What is the latest Total Non-Current Liabilities ratio of LUPIN ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹2,636 Cr |
| Mar2025 | ₹2,390 Cr |
| Mar2024 | ₹820 Cr |
| Mar2023 | ₹992 Cr |
| Mar2022 | ₹1,153 Cr |
How is Total Non-Current Liabilities of LUPIN Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,636 Cr | 10.27 | |
| Mar2025 | ₹2,390 Cr | 191.57 | |
| Mar2024 | ₹820 Cr | -17.38 | |
| Mar2023 | ₹992 Cr | -13.96 | |
| Mar2022 | ₹1,153 Cr | - | |
Compare Total Non-Current Liabilities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹96,536.0 Cr | -3.1% | -11.7% | 12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | -3.1% |
-11.7% |
12.5% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses